Lymphoplasmacytic lymphoma: Difference between revisions

From IDWiki
m (Text replacement - "Clinical Presentation" to "Clinical Manifestations")
No edit summary
 
Line 1: Line 1:
== Definition ==
== Definition ==


* Low-grade B-cell neoplasm frequently causing an IgM gammopathy (at which point it is called Waldenstrom's macroglobulinemia)
* Low-grade B-cell neoplasm frequently causing an IgM gammopathy (at which point it is called [[Waldenström macroglobulinemia]])


== Investigations ==
== Investigations ==
Line 10: Line 10:


* Hyperviscosity, including neurological symptoms
* Hyperviscosity, including neurological symptoms
* Peripheral neuropathy
* [[Peripheral neuropathy]]
* Lymphadenopathy, organomegaly, cytopenia
* Lymphadenopathy, organomegaly, cytopenia
* Constitutional symptoms
* Constitutional symptoms
Line 19: Line 19:
* Treatment only indicated if symptoms progressing
* Treatment only indicated if symptoms progressing
* From most to least effective (and most to least side effects):
* From most to least effective (and most to least side effects):
** RCP: rituximab, cyclophosphamide, prednisone (or dexamethasone for DRC)
** [[RCP]]: [[rituximab]], [[cyclophosphamide]], [[prednisone]] (or [[dexamethasone]] for [[DRC]])
** BR: bendamustine/rituximab
** [[BR]]: [[bendamustine]]/[[rituximab]]
** Chlorambucil/Obinutuzumab
** [[Chlorambucil]]/[[Obinutuzumab]]
** Ibrutinib
** [[Ibrutinib]]
* Before chemotherapy, screen for hepatitis B +/- TB/Strongy
* Before chemotherapy, screen for [[hepatitis B]] +/- [[TB]]/[[Strongyloides]]


[[Category:Hematology]]
[[Category:Hematology]]

Latest revision as of 18:03, 26 July 2023

Definition

Investigations

  • SPEP and immunofixation showing IgM-kappa M-protein

Clinical Manifestations

  • Hyperviscosity, including neurological symptoms
  • Peripheral neuropathy
  • Lymphadenopathy, organomegaly, cytopenia
  • Constitutional symptoms

Management